Agenda
Tentatively, we will begin the meeting on June 13, 2019 at 8:30am and will end approximately at 5:00pm. The meeting will resume at the Hilton Rockville Hotel with a working dinner from 6:30pm to 9pm.
On June 14th, the meeting will resume at 8:30am – 3:00pm. We will facilitate transportation to the airport or hotel on the last day of the meeting.
Topics under consideration include:
- KRAS, LKB1 and Related Pathways
- Therapeutic Resistance
- Clinical Trials and Cooperative Group Efforts
- Novel Targets
- Premalignancy, Risk Stratification and Chemoprevention
- EGFR Fusions and Other Signaling Pathways
- Molecular Profiling and Biomarkers
- Small Cell Lung Cancer
- Immunotherapy
- Patient/Research Advocate issues
The final agenda will be based on the abstracts received will be posted in June.